sur HYBRIGENICS (EPA:ALHYG)
ATON Invests €500K in Bcell Design for its Commercial Expansion
The ATON Group, listed on Euronext Growth Paris, has announced a new investment of €500,000 through its investor BEORA. This 21st tranche involves 200 bonds redeemable in shares (ORA), each with a value of €2,500. The entire amount is earmarked for Bcell Design, a subsidiary specializing in the development of monoclonal antibodies for in vitro diagnostics.
This financial support aims to strengthen Bcell Design's commercial capabilities in France and internationally. In parallel, existing Bcell Design shareholders have contributed an additional €400,000. The objective is to enhance the commercial value of Bcell Design's technological platforms, while simultaneously establishing partnerships with university hospitals to validate its innovative solutions.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de HYBRIGENICS